NCT05917106View on ClinicalTrials.gov

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

December 26, 2022

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2030

Conditions
CarcinomaRenal Cell CarcinomaRCCKidney NeoplasmsKidney Cancer
Trial Locations (1)

210000

RECRUITING

Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China, Nanjing

All Listed Sponsors
lead

Jinling Hospital, China

OTHER